http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1240903-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-665
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
filingDate 1999-07-15^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feb120ac9cddb7f87f5c2cb671462be5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8def5dca72ff10849c1bdee77487966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_806a157df34f5b6e9e5cc15579b8b7dc
publicationDate 2003-02-12^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1240903-A3
titleOfInvention Combination of calcium (3S) tetrahydro-3-furanyl(1S,2R)-3- [[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy) propylcarbamate with ritonavir
abstract The invention relates to calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)npropylcarbamatencombined with the HIV protease inhibitor 10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)4-thiazolyl]-3,6-dioxo-8,1n1-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oicnacid, 5-thiazolylmethyl ester (ritonavir), and tonthe use thereof in the treatment of diseases caused by retroviruses.
priorityDate 1998-07-18^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0018384-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0100635-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9964001-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9933815-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9933792-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9933793-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422977858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID392622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230493305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21917709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227074745
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID31931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86689399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57017665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398153
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID31931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430827746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505741

Showing number of triples: 1 to 47 of 47.